1. Home
  2. ICL vs AMRX Comparison

ICL vs AMRX Comparison

Compare ICL & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICL Group Ltd.

ICL

ICL Group Ltd.

HOLD

Current Price

$4.66

Market Cap

7.3B

Sector

Industrials

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$21.18

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICL
AMRX
Founded
1968
2002
Country
Israel
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
6.4B
IPO Year
2001
2018

Fundamental Metrics

Financial Performance
Metric
ICL
AMRX
Price
$4.66
$21.18
Analyst Decision
Hold
Strong Buy
Analyst Count
4
7
Target Price
$5.74
★ $23.00
AVG Volume (30 Days)
1.5M
★ 3.1M
Earning Date
11-11-2026
11-03-2026
Dividend Yield
★ 3.59%
N/A
EPS Growth
N/A
★ 157.89
EPS
N/A
★ 0.37
Revenue
N/A
N/A
Revenue This Year
$11.76
$4.56
Revenue Next Year
$2.59
$9.33
P/E Ratio
★ $31.41
$57.89
Revenue Growth
N/A
N/A
52 Week Low
$4.63
$9.99
52 Week High
$6.97
$21.43

Technical Indicators

Market Signals
Indicator
ICL
AMRX
Relative Strength Index (RSI) 32.71 65.27
Support Level N/A $16.59
Resistance Level $5.86 N/A
Average True Range (ATR) 0.11 0.60
MACD -0.00 0.12
Stochastic Oscillator 6.73 82.70

Price Performance

Historical Comparison
ICL
AMRX

About ICL ICL Group Ltd.

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates revenue from Brazil, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: